Project Grant K99NS138490
Award Date
9/18/24
Completion Date
8/31/26
Dollars Obligated
$142K
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Mayo Clinic (Y2K4F9RPRRG7)
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $443,354 to the University of Pittsburgh to conduct research on targeting the hexosamine biosynthetic pathway in pediatric brain tumors, specifically diffuse midline gliomas (DMG) harboring the H3K27M mutation. The research aims to investigate how this metabolic pathway supports tumor growth...
The federal Project Grant award R21NS142585 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $460,940 award, effective June 1, 2025 through May 31, 2027, supports research by The University of Texas MD Anderson Cancer Center to investigate the impact of glioma-associated germline risk alleles on neurodevelopmental trajectories. The goal is to...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $717,802 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Georgia Research Foundation, Inc. The grant supports research aimed at elucidating the cellular and molecular mechanisms underlying the development of a subtype of high-grade glioma brain tumors known as HGG-G34. Specifically, the research project seeks to unravel the...
This $195,896 Project Grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to define the circuit connectivity between glioblastoma, a fatal brain cancer, and diverse neuronal populations in the mouse brain. The research aims to elucidate the role of cholinergic neuromodulatory inputs in regulating glioma progression, with the goal of...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 24-month, $430,375 Project Grant (CFDA 93.853) to Emory University to develop human organoid models for pediatric high-grade gliomas (PHGGs). The research aims to 1) create PHGG organoid models using human patient-derived cancer stem cells and 2) model how interactions between PHGG cells and the human neural microenvironment affect responses to tyrosine kinase inhibitors and other anti-tumor drugs. The goal is to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $190,485 to Trustees of Indiana University, doing business as Indiana University Indianapolis, to conduct research into the molecular mechanisms underlying differentiation failure in neuroepithelial stem cells with NF2 gene mutations. The research aims to identify the cellular...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $457,714 to the University of California, Davis to conduct research on the role of post-transcriptional regulation on cortical cell fate specification. The research aims to uncover the dynamics of microRNA (miRNA) expression and the mRNAs targeted by miRNA pairs in neural...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $163,640 to the University of Virginia to develop novel non-viral gene delivery platforms for the treatment of glioblastoma, an aggressive brain cancer. The research aims to improve the therapeutic accumulation and delivery of gene therapies by leveraging brain-penetrating nanoparticles and focused ultrasound technology. Key objectives include investigating the tumor-targeting and...
This federal Project Grant award of $604,852.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to investigate the role of glial progenitor cells in the initiation and recurrence of medulloblastoma, the most common malignant childhood brain tumor. The research aims to advance the understanding of tumor heterogeneity,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA program 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders", is funding research to investigate how physical force regulates gene expression and transcriptional states in glioblastoma (GBM), the most common malignant brain tumor. The $452,375 award to The Trustees of Columbia University will leverage the diverse landscape of tissue stiffness in...